======= DLX1 ======= == Gene Information == * **Official Symbol**: DLX1 * **Official Name**: distal-less homeobox 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1745|1745]] * **UniProt**: [[https://www.uniprot.org/uniprot/P56177|P56177]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DLX1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DLX1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600029|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of a homeobox transcription factor gene family similiar to the Drosophila distal-less gene. The encoded protein is localized to the nucleus where it may function as a transcriptional regulator of signals from multiple TGF-{beta} superfamily members. The encoded protein may play a role in the control of craniofacial patterning and the differentiation and survival of inhibitory neurons in the forebrain. This gene is located in a tail-to-tail configuration with another member of the family on the long arm of chromosome 2. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Plays a role as a transcriptional activator or repressor (PubMed:14671321). Inhibits several cytokine signaling pathways, such as TGFB1, activin-A/INHBA and BMP4 by interfering with the transcriptional stimulatory activity of transcription factors, such as MSX2, FAST2, SMAD2 and SMAD3 during hematopoietic cell differentiation (PubMed:14671321). Plays a role in terminal differentiation of interneurons, such as amacrine and bipolar cells in the developing retina (By similarity). Likely to play a regulatory role in the development of the ventral forebrain (By similarity). May play a role in craniofacial patterning and morphogenesis and may be involved in the early development of diencephalic subdivisions (By similarity). {ECO:0000250|UniProtKB:Q64317, ECO:0000269|PubMed:14671321}. |Homeobox| |positive regulation of retina development in camera-type eye| |cerebral cortex GABAergic interneuron fate commitment| |regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment| |commitment of multipotent stem cells to neuronal lineage in forebrain| |positive regulation of amacrine cell differentiation| |positive regulation of neural retina development| |regulation of amacrine cell differentiation| |regulation of neural retina development| |regulation of retina development in camera-type eye| |negative regulation of photoreceptor cell differentiation| |regulation of photoreceptor cell differentiation| |forebrain neuron fate commitment| |cerebral cortex GABAergic interneuron differentiation| |negative regulation of oligodendrocyte differentiation| |GABAergic neuron differentiation| |regulation of transcription involved in cell fate commitment| |cerebral cortex neuron differentiation| |subpallium development| |negative regulation of glial cell differentiation| |proximal/distal pattern formation| |regulation of oligodendrocyte differentiation| |negative regulation of gliogenesis| |negative regulation of Notch signaling pathway| |negative regulation of BMP signaling pathway| |forebrain neuron differentiation| |neuron fate commitment| |forebrain generation of neurons| |regulation of glial cell differentiation| |negative regulation of cellular response to transforming growth factor beta stimulus| |hippocampus development| |odontogenesis of dentin-containing tooth| |regulation of BMP signaling pathway| |regulation of Notch signaling pathway| |response to BMP| |cellular response to BMP stimulus| |limbic system development| |negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |regulation of cellular response to transforming growth factor beta stimulus| |regulation of gliogenesis| |odontogenesis| |embryonic skeletal system development| |negative regulation of neuron apoptotic process| |negative regulation of cellular response to growth factor stimulus| |cellular response to transforming growth factor beta stimulus| |response to transforming growth factor beta| |pallium development| |central nervous system neuron differentiation| |negative regulation of neuron death| |regulation of neuron apoptotic process| |negative regulation of neuron differentiation| |regulation of transmembrane receptor protein serine/threonine kinase signaling pathway| |cell fate commitment| |telencephalon development| |regulation of cellular response to growth factor stimulus| |negative regulation of neurogenesis| |regulation of neuron death| |negative regulation of nervous system development| |regionalization| |negative regulation of cell development| |positive regulation of neuron differentiation| |forebrain development| |chromatin binding| |sequence-specific DNA binding| |pattern specification process| |positive regulation of neurogenesis| |skeletal system development| |cellular response to growth factor stimulus| |RNA polymerase II proximal promoter sequence-specific DNA binding| |response to growth factor| |positive regulation of nervous system development| |positive regulation of cell development| |chordate embryonic development| |embryo development ending in birth or egg hatching| |regulation of neuron differentiation| |DNA-binding transcription factor activity| |negative regulation of cell differentiation| |brain development| |head development| |regulation of neurogenesis| |negative regulation of transcription by RNA polymerase II| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |animal organ morphogenesis| |positive regulation of cell differentiation| |embryo development| |central nervous system development| |negative regulation of cell death| |neuron differentiation| |negative regulation of transcription, DNA-templated| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of developmental process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |generation of neurons| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |negative regulation of response to stimulus| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of cell death| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12495 * **Expression level (log2 read counts)**: 0.61 {{:chemogenomics:nalm6 dist.png?nolink |}}